pharyngeal-cervical-brachial variant of Guillain-Barre syndrome

Summary

pharyngeal-cervical-brachial variant of Guillain-Barre syndrome (MONDO:0016496) is a disease. A subtype of Guillain-Barre syndrome — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	pharyngeal-cervical-brachial variant of Guillain-Barre syndrome
Mondo ID	MONDO:0016496
Orphanet	231426
UMLS	C5190783
MedGen	1682775
GARD	0020614
Is cancer (heuristic)	no

Also known as: PCB variant of GBS · PCB variant of Guillain-Barre syndrome · PCB variant of Guillain-Barré syndrome · pharyngeal-cervical-brachial weakness · pharyngo-cervico-brachial variant of GBS · pharyngo-cervico-brachial variant of Guillain-Barre syndrome · pharyngo-cervico-brachial variant of Guillain-Barré syndrome

Disease family

This is a subtype of Guillain-Barre syndrome. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › autoimmune disorder of the nervous system › autoimmune disorder of peripheral nervous system › Guillain-Barre syndrome › pharyngeal-cervical-brachial variant of Guillain-Barre syndrome

Related subtypes (10): Guillain-Barre syndrome, familial, paraparetic variant of Guillain-Barre syndrome, acute pure sensory neuropathy, autoimmune autonomic ganglionopathy, acute sensory ataxic neuropathy, facial diplegia with paresthesias, acute inflammatory demyelinating polyradiculoneuropathy, acute motor and sensory axonal neuropathy, acute motor axonal neuropathy, polyneuropathy, inflammatory demyelinating, chronic

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.